MedPath

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

Phase 2
Terminated
Conditions
Persistent Cough in IPF
Chronic Cough
IPF
Interventions
Drug: Placebo
Registration Number
NCT03864328
Lead Sponsor
Respivant Sciences GmbH
Brief Summary

Idiopathic pulmonary fibrosis (IPF) is a rare, progressive life-threatening disease that is characterized by exertional dyspnea and persistent dry cough.

Cough in IPF is both a presenting and a complicating clinical feature, which affects approximately three quarters of IPF cases. It is often a debilitating symptom that adversely affects quality of life (QoL) and is usually refractory to medical therapy.

Inhaled RVT-1601 (formerly, PA101B), a new inhalation formulation of cromolyn sodium delivered via the eFlow® Closed System (CS) nebulizer, is being evaluated in this Phase 2b study for the treatment of persistent cough in patients with IPF.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
108
Inclusion Criteria
  • Male or female subjects age 40 through 89 years
  • Confirmed diagnosis of IPF with clinical features consistent with the current clinical practice guidelines
  • Persistent cough for at least 8 weeks that is primarily due to IPF and not responsive to anti-tussive therapy
  • Daytime cough severity score of ≥ 40 mm on a 100-mm VAS
  • 24-hour average cough count of at least 10 coughs per hour
  • Forced Vital Capacity (FVC) > 45% predicted value within 4 weeks
  • Diffusion capacity for carbon monoxide corrected for hemoglobin (DLCOc) > 30% predicted value within 4 weeks
  • Life expectancy of at least 12 months
Exclusion Criteria
  • Current or recent history of clinically significant medical condition, laboratory abnormality, or illness that could place the subject at risk or compromise the quality of the study data
  • Significant coronary artery disease (i.e., myocardial infarction within 6 months or unstable angina within 1 month)
  • Upper or lower respiratory tract infection within 4 weeks
  • Acute exacerbation of IPF within 6 months
  • Lung transplantation expected within 12 months
  • Requiring supplemental O2 > 4 litres/min to maintain peripheral arterial O2 saturation (SpO2) > 88% at rest
  • History of malignancy likely to result in significant disability or likely to require significant medical or surgical intervention within the next 2 years
  • Current smoker (i.e., use of tobacco products within the last 3 months)
  • Current or recent history of drug or alcohol abuse within 12 months
  • Participation in any other investigational drug study within 4 weeks
  • Use of certain drugs for cough management within 4 weeks: prednisone, opiates, baclofen, gabapentin, pregabalin, thalidomide, amitriptyline, inhaled corticosteroids, or inhaled bronchodilators
  • Use of ACE inhibitors or cromolyn sodium within 4 weeks
  • Females who are pregnant or breastfeeding, or if of child-bearing potential unwilling to practice acceptable means of birth control during the study
  • History of hypersensitivity or intolerance to cromolyn sodium

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RVT-1601 Low DoseRVT-1601-
RVT-1601 Mid DoseRVT-1601-
PlaceboPlacebo-
RVT-1601 High DoseRVT-1601-
Primary Outcome Measures
NameTimeMethod
Change in 24-hour average cough count12 weeks

Objective cough count monitoring performed using a digital recording device.

Secondary Outcome Measures
NameTimeMethod
Change in cough severity12 weeks

Cough severity assessed using Visual Analog Scale (VAS), a single-item questionnaire using 100-point scale ranging from 0 (no cough) to 100 (extremely severe cough).

Change in cough-specific QoL12 weeks

Cough-specific QoL assessed using Leicester Cough Questionnaire (LCQ), a 19-item questionnaire designed to measure impact of cough in three domains (physical, psychological and social), each domain ranging from 1 to 7 and LCQ total score ranging from 3 to 21, with the higher scores corresponding with better QoL.

Trial Locations

Locations (81)

Renstar Medical Research

🇺🇸

Ocala, Florida, United States

American Health Research

🇺🇸

Charlotte, North Carolina, United States

Ascension Medical Group / St. Vincent's Lung Institute

🇺🇸

Jacksonville, Florida, United States

Loyola University

🇺🇸

Maywood, Illinois, United States

Cornell University Weill Cornell Medical College

🇺🇸

New York, New York, United States

University of Padova

🇮🇹

Padova, Italy

University Clinic Saint-Luc

🇧🇪

Brussel, Belgium

Mater Research

🇦🇺

South Brisbane, Quensland, Australia

Thomayer Hospital

🇨🇿

Prague, Czechia

VU Medical Center

🇳🇱

Amsterdam, Netherlands

A.O.U. Policlinico di Modena

🇮🇹

Modena, Italy

Cukurova University

🇹🇷

Adana, Turkey

Frankston Hospital-Peninsula Health

🇦🇺

Frankston, Victoria, Australia

Evangelische Lungerklinik Berlin

🇩🇪

Berlin, Germany

Greenlane Clinical Center

🇳🇿

Auckland, New Zealand

Universitaire Ziekenhuizen Leuven

🇧🇪

Leuven, Belgium

Pneumologische Klinik Waldhof Elgerhausen

🇩🇪

Greifenstein, Germany

University Heidelberg

🇩🇪

Heidelberg, Germany

Austin Hospital

🇦🇺

Heidelberg, Victoria, Australia

Lung Research Quensland

🇦🇺

Chermside, Quensland, Australia

University Clinic Bonn

🇩🇪

Bonn, Germany

Ruhrlandklinik-Universitätsmedizin Essen

🇩🇪

Essen, Germany

Krankenhaus Bethanian

🇩🇪

Solingen, Germany

Dalhousie University

🇨🇦

Halifax, Canada

Medizinische Hochshule Hannover

🇩🇪

Hannover, Germany

University of Otago

🇳🇿

Christchurch, New Zealand

Johns Hopkins University School of Medicine

🇺🇸

Baltimore, Maryland, United States

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

Pulmonix, LLC

🇺🇸

Greensboro, North Carolina, United States

St. Luke's Hospital

🇺🇸

Chesterfield, Missouri, United States

Temple University School of Medicine

🇺🇸

Philadelphia, Pennsylvania, United States

Spartanburg Medical Research

🇺🇸

Spartanburg, South Carolina, United States

UT Southwester Medical Center

🇺🇸

Dallas, Texas, United States

Fiona Stanley Hospital

🇦🇺

Murdoch, Western Australia, Australia

University of Miami

🇺🇸

Miami, Florida, United States

University of Washington School of Medicine

🇺🇸

Seattle, Washington, United States

Trialswest

🇦🇺

Perth, Western Australia, Australia

University of Alabama

🇺🇸

Birmingham, Alabama, United States

University of Utah Hospitals & Clinics

🇺🇸

Salt Lake City, Utah, United States

National Jewish Health

🇺🇸

Denver, Colorado, United States

University California San Francisco

🇺🇸

San Francisco, California, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Siena University Hospital

🇮🇹

Siena, Italy

Tulane University

🇺🇸

New Orleans, Louisiana, United States

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

Duke University

🇺🇸

Durham, North Carolina, United States

University of Leicester

🇬🇧

Leicester, United Kingdom

McMaster University

🇨🇦

Hamilton, Canada

Centre Hospitalier Universitaire de Montreal

🇨🇦

Montréal, Canada

University Health Network, Toronto General Hospital

🇨🇦

Toronto, Canada

St. Paul's Hospital

🇨🇦

Vancouver, Canada

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

Alfred Health

🇦🇺

Westmead, Victoria, Australia

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Royal Prince Alfred Hospital

🇦🇺

Camperdown, New South Wales, Australia

Westmead Hospital

🇦🇺

Westmead, New South Wales, Australia

Bologna University Hospital

🇮🇹

Bologna, Italy

University of Catania

🇮🇹

Catania, Italy

Lungenfachklinik Immenhausen

🇩🇪

Immenhausen, Germany

University of Torino

🇮🇹

Torino, Italy

St. Antonius Ziekenhuis

🇳🇱

Nieuwegein, Netherlands

Fondazione Policlinico Universitario Agostino Gemelli

🇮🇹

Roma, Italy

Haaglanden Medical Center

🇳🇱

Den Haag, Netherlands

Zuyderland Medical Center

🇳🇱

Heerlen, Netherlands

Erasmus Medical Center

🇳🇱

Rotterdam, Netherlands

Istanbul University Istanbul Medical Faculty

🇹🇷

Istanbul, Turkey

Ege University Hospital

🇹🇷

İzmir, Turkey

Waikato Hospital

🇳🇿

Hamilton, New Zealand

Royal Papworth Hospital

🇬🇧

Cambridge, United Kingdom

University Hospital Aintree

🇬🇧

Liverpool, United Kingdom

University of Manchester

🇬🇧

Manchester, United Kingdom

Nottingham University Hospital

🇬🇧

Nottingham, United Kingdom

University Hospital Southampton

🇬🇧

Southampton, United Kingdom

University of California Davis

🇺🇸

Sacramento, California, United States

Tampa General Hospital / Uni of South Florida

🇺🇸

Tampa, Florida, United States

Mayo Clinic - Rochester

🇺🇸

Rochester, Minnesota, United States

Universty of Michigan

🇺🇸

Ann Arbor, Michigan, United States

Royal Brompton Hospital

🇬🇧

London, United Kingdom

Castle Hill Hospital

🇬🇧

Cottingham, East Yorkshire, United Kingdom

University of Edinburgh

🇬🇧

Edinburgh, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath